Pharma companies place more importance on supply chains in 2016
Frankfurt, Germany: Consulting company Miebach has released a new pharma survey for 2016 which reveals that the industry is placing more importance on supply chain and logistics than it ever has in the past.
The top subjects in pharmaceutical logistics are end-to-end supply chain visibility and optimising distribution networks, says the report. The increasing volume of refrigerated and frozen products and serialisation of product codes are further challenges that supply chain managers are facing.
“Our European study clearly shows that most pharmaceutical companies see the European market as a whole region, while national borders are becoming less important, except for specific legislation or distribution channels,” says Martin Eckert, global pharma expert & director, Miebach Consulting.
Topics like improving supplier management (86 %), end-to-end supply chain visibility (93 %), improving forecasting accuracy (84 %) and track & trace (82 %) are some of the most significant issues for management, very much in line with the previous Miebach pharma study from 2012. Optimisation through automation (64 %), outsourcing (62 %) and constructing new warehouses compliant with GxP guidelines (54 %) are also important topics.
Posted on July 4, 2016
by Edwin Kalischnig